A growing body of evidence suggests that ZEB1 promotes tumor initiation and malignant progression in breast cancer patients.5,6 Therefore, identifying the signaling pathways that regulate ZEB1 stabilization may lead to the development of improved antineoplastic therapies. Here, ZEB1 is linked to breast carcinoma.